• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,264.33 0.00
( 0.00%)
Global Indices
Nasdaq
51,705.57 482.31
(0.94%)
Dow Jones
7,575.20 122.74
(1.65%)
Hang Seng
69,318.21 3,298.17
(5.00%)
Nikkei 225
10,435.69 -36.03
(-0.34%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Bharat Immunological & Biological Corporation Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524663
INE994B01014
-7.5352246
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
74.01
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Banco Products (India) consolidated net profit declines 3.95% in the March 2026 quarter
May 29,2026
Net profit of Banco Products (India) declined 3.95% to Rs 147.43 crore in the quarter ended March 2026 as against Rs 153.50 crore during the previous quarter ended March 2025. Sales rose 25.64% to Rs 1091.10 crore in the quarter ended March 2026 as against Rs 868.40 crore during the previous quarter ended March 2025.

For the full year,net profit rose 22.94% to Rs 481.68 crore in the year ended March 2026 as against Rs 391.80 crore during the previous year ended March 2025. Sales rose 21.34% to Rs 3867.43 crore in the year ended March 2026 as against Rs 3187.24 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1091.10868.40 26 3867.433187.24 21
OPM %20.6324.68 -17.6119.18 -
PBDT242.47225.18 8 757.16628.55 20
PBT182.86189.67 -4 622.65534.21 17
NP147.43153.50 -4 481.68391.80 23